CO2 Laser Therapy for the Treatment of GSM in Patients With Breast Cancer
Given the need for an effective, non-hormonal treatment for Genitourinary syndrome of menopause GSM) symptoms in breast cancer survivors, the reported efficacy of fractional CO2 laser as such a treatment in retrospective studies, the study aims to evaluate the efficacy of CO2 laser for the treatment of GSM in breast cancer patients, in a prospective, randomized, blinded, placebo-controlled trial.
Breast Cancer|Genitourinary Syndrome of Menopause
DEVICE: Fractional/Pixel CO2 laser
Change in dryness, Change in VAS before and after completion of treatment for dryness, Follow up after 3 treatments and at 1 month, 3 months and 6 months after last treatment.|Change in dyspareunia, Change in VAS before and after completion of treatment for dyspareunia, Follow up after 3 treatments and at 1 month, 3 months and 6 months after last treatment.
Given the need for an effective, non-hormonal treatment for Genitourinary syndrome of menopause GSM) symptoms in breast cancer survivors, the reported efficacy of fractional CO2 laser as such a treatment in retrospective studies, the study aims to evaluate the efficacy of CO2 laser for the treatment of GSM in breast cancer patients, in a prospective, randomized, blinded, placebo-controlled trial.